Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
Acorda Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 27, 2023
Acorda Therapeutics reported fiscal year 2020 executive compensation information on April 27, 2023.
In 2020, five executives at Acorda Therapeutics received on average a compensation package of $890K, a 41% decrease compared to previous year.
Average pay of disclosed executives at Acorda Therapeutics
Ron Cohen, Chief Executive Officer, received $1.5M in total, which decreased by 26% compared to 2019. 53% of Cohen's compensation, or $796K, was in salary. Cohen also received $700K in non-equity incentive plan and $8.6K in other compensation.
For fiscal year 2020, the median employee pay was $189,329 at Acorda Therapeutics. Therefore, the ratio of Ron Cohen's pay to the median employee pay was 8 to one.
Burkhard Blank, Chief Medical Officer, received a compensation package of $861K, which decreased by 28% compared to previous year. 62% of the compensation package, or $533K, was in salary.
Lauren Sabella, Chief Commercial Officer, earned $759K in 2020, a 18% decrease compared to previous year.
David Lawrence, Former Chief, Business Operations and Principal Accounting Officer, received $720K in 2020, which decreases by 21% compared to 2019.
Kerry Clem, Chief Commercial Officer, earned $604K in 2020.
Related executives
Kerry Clem
Acorda Therapeutics
Chief Commercial Officer
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
David Lawrence
Acorda Therapeutics
Former Chief, Business Operations and Principal Accounting Officer
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
Lauren Sabella
Acorda Therapeutics
Chief Operating Officer
You may also like
Source: SEC filing on April 27, 2023.